Canadian contract research organization JSS Medical Research Inc. has acquired fellow Canadian CRO Integrated Research Inc. (IRC), to become the largest Canadian owned CRO. As part of the acquisition IRI will continue to operate as a fully-owned subsidiary of JSS.
“This is an important milestone for JSS and IRI as well as for the Canadian Industry. The merger of JSS and IRI creates a robust and stable Canadian based and owned CRO that has the critical mass, expertise and most importantly, experienced senior management that will offer highest quality services covering all of the scientific and operational aspects of clinical research. Now a local CRO will be able to provide the same services as the large multinationals, while maintaining the intimate client relationships that have contributed to our longevity and client loyalty over the last twenty years” stated Dr. John S. Sampalis, CEO and president of JSS Medical Research.
IRI is located in Dollard-des-Ormeaux, QC and was founded over two decades ago by Joanne E. Watson M.Sc. and it provides clinical research support to pharmaceutical, medical device and biotechnology companies. The company’s core service offerings include study start-up, project management, site management, data management, and monitoring covering a wide range of therapeutic areas.
JSS Medical Research was also founded approximately twenty years ago by Dr. John S. Sampalis, a clinical epidemiologist from McGill University. Clinical research, medical science, epidemiology and biostatistics were the cornerstones of the foundation of JSS. Clinical operations were incorporated on the scientific foundation and hence the company evolved as a fully integrated CRO offering services that include strategic consulting, study conceptualization, study design, protocol development, execution, project management, site management, monitoring, data management, biostatistical consulting and analysis, and medical writing.
The deal is the latest in a series of deals to expand the company’s core services. Last September, JSS Medical Research acquired LatAm Clinical Trials, a multinational CRO operating in South and Central America.